The impact of trauma relevant concentrations of prostaglandin E 2 on the anti-microbial activity of the innate immune system.
Level 3 - non-randomized controlled study
Prospective non-randomized cohort study with ex vivo mechanistic human cellular assays
PubMed 39502706 · doi:10.3389/fimmu.2024.1401185
What was done
Blood samples were collected from 95 trauma patients (injury severity score ≥ 8) across three time points: pre-hospital (≤ 2 hours), acute (4-12 hours), and subacute (48-72 hours) post-injury. The authors measured serum concentrations of PGE2 and albumin, alongside expression of enzymes and receptors in PGE2 synthesis and signaling. Ex vivo assays evaluated monocyte cytokine production, neutrophil reactive oxygen species, and phagocytosis. Patient leukocytes were treated with COX inhibitors (indomethacin, NS-398) or a PKA inhibitor (H89). Healthy control leukocytes were exposed to trauma-relevant PGE2 concentrations to evaluate antimicrobial function and efferocytosis, and to mitochondrial DAMPs (mtDAMPs) to examine COX-2 induction.
What was found
The abstract reports no numeric values, standard deviations, or p-values. Circulating PGE2 concentrations peaked ≤ 2 hours post-injury, coinciding with significantly reduced levels of albumin and impaired LPS-induced monocyte cytokine production. Leukocytes from trauma patients displayed significantly higher COX-2 and phospholipase A2 expression. Ex vivo treatment with indomethacin, NS-398, or H89 enhanced LPS-induced cytokine production and neutrophil extracellular trap generation. In healthy control cells, trauma-level PGE2 suppressed antimicrobial activity of monocytes, neutrophils, and monocyte-derived macrophages without affecting efferocytosis. mtDAMPs significantly increased leukocyte COX-2 expression and PGE2 generation via formyl-peptide receptor-1.
Why it matters
This study demonstrates that severe injury triggers a rapid, mtDAMP-mediated surge in circulating PGE2 that directly suppresses innate antimicrobial responses. Targeting COX-2 or downstream PKA signaling represents a potential strategy to reverse post-traumatic immunoparalysis.
Limits
No exact numbers, effect sizes, or confidence intervals are reported in the abstract. The number of healthy control subjects is not stated. Reversal of immune suppression was demonstrated only in ex vivo cell models rather than clinical in vivo interventions, and clinical endpoints like secondary infection or mortality were not assessed.
Cited by
- contradicts Blocking prostaglandin E2 (PGE2) with NSAIDs such as indomethacin or ibuprofen suppresses the immune system and increases susceptibility to opportunistic infections.